AAKP Testifies Before MEDCAC Panel on ESA Use in Kidney Transplant

David Scott
Tampa, FL; Thursday, January 20, 2011 – On Wednesday, January 19, 2011, the American Association of Kidney Patients (AAKP) testified before the Center for Medicare and Medicaid Services’(CMS) Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) on the impact of erythropoiesis stimulating agents (ESAs)
Read More

AAKP Applauds Latest GAO Report on Oral Drugs and ESRD Bundle

David Scott
Tampa, FL; March 28, 2011 – The American Association of Kidney Patients today congratulated the Government Accountability Office, the GAO, on the report issued this week entitled End Stage Renal Disease: CMS Should Assess Adequacy of Payment When Certain Oral Drugs Are Included and Ensure Availability of Quality Monitoring Data.
Read More